[1]
“PHARMACOLOGICAL MANAGEMENT OF GRAVES’ DISEASE: CURRENT EVIDENCE AND EMERGING THERAPEUTIC TARGETS”, ijms, vol. 6, no. 4, pp. 774–778, Apr. 2026, doi: 10.55640/.